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background: Miscarriage is the spontaneous loss of a pregnancy before 12 weeks (early miscarriage) or from 12 to 24 weeks (late mis-
carriage) of gestation. Miscarriage occurs in one in ﬁve pregnancies and can have considerable physiological and psychological implications for
the patient. It is also associated with signiﬁcant health care costs. There is evidence that potentially preventable infections may account for up
to 15% of early miscarriages and up to 66% of late miscarriages. However, the provision of associated screening and management algorithms
is inconsistent for newly pregnantwomen. Here, we review recent population-based studies on infections that have been shown to be associated
with miscarriage.
methods:Ouraimwas toexaminewhere thecurrent scientiﬁc focus lieswith regards to the roleof infection inmiscarriage. Papersdating from
June 2009 with key words ‘miscarriage’ and ‘infection’ or ‘infections’ were identiﬁed in PubMed (292 and 327 papers, respectively, on 2 June
2014). Relevant human studies (meta-analyses, case–control studies, cohort studies or case series) were included. Single case reports were
excluded. The studies were scored based on the Newcastle – Ottawa Quality Assessment Scale.
results: The association of systemic infections with malaria, brucellosis, cytomegalovirus and human immunodeﬁciency virus, dengue fever,
inﬂuenza virus and of vaginal infection with bacterial vaginosis, with increased risk of miscarriage has been demonstrated. Q fever, adeno-asso-
ciated virus, Bocavirus, Hepatitis C andMycoplasma genitalium infections do not appear to affect pregnancy outcome. The effects of Chlamydia
trachomatis, Toxoplasma gondii, human papillomavirus, herpes simplex virus, parvovirus B19, Hepatitis B and polyomavirus BK infections remain
controversial, as some studies indicate increasedmiscarriage risk andothers showno increased risk. The latest data on rubella and syphilis indicate
increased antenatal screening worldwide and a decrease in the frequency of their reported associations with pregnancy failure. Though various
pathogens have been associated with miscarriage, the mechanism(s) of infection-induced miscarriage are not yet fully elucidated.
conclusions: Further research is required to clarifywhether certain infections do increasemiscarriage risk andwhether screening of newly
pregnant women for treatable infections would improve reproductive outcomes.
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Introduction
Miscarriage is one of the most common yet under-studied adverse preg-
nancy outcomes. In the majority of cases the effects of a miscarriage on
women’s health are not serious and may be unreported. However in the
most serious cases symptomscan includepain,bleedinganda riskofhaem-
orrhage. Feelings of loss andgrief are also commonand thepsychology and
mental health of those affected can suffer (Engelhard et al., 2001).
For the purposes of this review ‘miscarriage’ is deﬁned as the
spontaneous loss of a pregnancy during the ﬁrst 24 weeks of gestation
(Fig. 1). For most women, a miscarriage is an individual event and will
be followed by a successful pregnancy (‘spontaneous miscarriage’,
termed ‘miscarriage’ from this point onwards). A small number (0.5–
1%) of women wishing to have children may experience three or more
successive miscarriages, a condition known as ‘recurrent miscarriage’
(Bulletti et al., 1996). ‘Early miscarriage’ is deﬁned as pregnancy loss
during the ﬁrst trimester of pregnancy (less than 12 weeks of gestation)
and occurs in up to one in ﬁve pregnancies. ‘Late miscarriage’ occurs
during the second trimester (12–24 weeks of gestation) and is less
common, occurring in 1–2% of pregnancies (Hay, 2004). Fetal death
from the 25th week of gestation onwards is deﬁned as stillbirth, an
outcome taken into consideration in some of the studies included
here, however it is not the main focus of this review.
Although miscarriage is considered the most common adverse
pregnancy outcome, worldwide ﬁgures are not available. In 2012–2013
there were 729 674 live births recorded in England and Wales (Ofﬁce
for National Statistics, 2012). Loss of one in ﬁve pregnancies suggests
that this ﬁgure is accompanied by 200 000 miscarriages. Statistics
from England and Wales for 2012/13 report that 39 800 miscarriages
resulted in a hospital stay (Ofﬁce for National Statistics, 2012). In an Aus-
tralian prospective cohort including 14 247women aged18–23years, the
rate of miscarriage varied from 11.3 to 86.5 per 100 live births amongst
different groups; overall, miscarriage occurred in 25% of the women in
the study when the women were 31–36 years old (Hure et al., 2012).
Aetiology of miscarriage
The causes of miscarriage are often unknown. However, in 50% of
early miscarriages the fetus exhibits chromosomal aberrations such as
a structural alteration or abnormal chromosomal numbers (Eiben
et al., 1990; Suzumori and Sugiura-Ogasawara, 2010). Several other
factors have been associated with increased risk of miscarriage. The
age of both parents has a signiﬁcant role as the risk of an adverse preg-
nancy outcome is increased if the parents are 35 years old or older
and it is 50% higher if the mother is 42 years of age (Fretts et al., 1995;
Nybo Andersen et al., 2000; de la Rochebrochard and Thonneau,
2002; Slama et al., 2005; Maconochie et al., 2007). In addition, factors
such as ethnic origin, psychological state of the mother, very low or
very high pre-pregnancy BMI, feelings of stress, use of non-steroidal anti-
inﬂammatory drugs, smoking and alcohol consumption have also been
associated with signiﬁcantly higher rates of miscarriage (Coste et al.,
1991;Nielsen et al., 2001; Sopori, 2002; Lashen et al., 2004;Maconochie
et al., 2007). Moreover, it has been reported that women whose ﬁrst
pregnancy resulted in miscarriage are at a higher risk of the second preg-
nancy resulting inmiscarriage comparedwithwomenwhohada livebirth
(Kashanian et al., 2006). Finally, a number of infections have been linked
to miscarriage (Benedetto et al., 2004) and to other adverse outcomes,
such as stillbirth (Goldenberg and Thompson, 2003) and preterm deliv-
ery (Garland et al., 2002). Speciﬁcally, 15% of earlymiscarriages and 66%
of late miscarriages have been attributed to infections (Srinivas et al.,
2006; Baud et al., 2008). In a recent study, 78% of 101 tissue samples
from miscarriage were infected with bacteria (chorioamnionitis),
whereas all the control samples from medically induced abortions
were uninfected (Allanson et al., 2010).
Methods
Theaimof this review is to summarize present knowledge regarding the roleof
infection inmiscarriage. Inorder tocombine themost recent ﬁndings regarding
infection and a potential association with miscarriage, we focused on studies
published in the past 5 years. Our aim was to investigate current evidence
regarding high-risk pathogens and scientiﬁc research trends. In PubMed,
using the key words ‘miscarriage’ combined with ‘infection’ and ‘infections’,
with ‘human’, ‘English language’ and ‘2009-present’ ﬁlters, articles published
in the past 5 years were identiﬁed. The search returned a total of 292 and
327 papers for ‘miscarriage infection’ and ‘miscarriage infections’ respectively
(up to 02/06/2014). From these, single case reports and studies in animals
were excluded. A total of 44 studies investigated the association of different
pathogens with miscarriage and the ﬁndings are presented in this review.
The studies were also scored by two individuals independently based on the
Newcastle - Ottawa Quality Assessment Scale for case control studies. The
score of random studies was further evaluated by two more individuals.
Results
Infections associated with miscarriage
An overview of all the studies analysed is presented in Supplementary
Table SI, including pathogen(s) investigated, outcome of the study and
Figure 1 Adverse pregnancy outcomes across the three trimesters of pregnancy.
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an estimation on the strength of each study, as described in Methods.
Some of the most common caveats addressed in this review were vari-
ation in sample size and detection techniques, whethermultivariate ana-
lysis was implemented or not and variation in study design.
Bacterial infections
Bacterial vaginosis
In healthywomen, thenormal genital tract ﬂoraconsists for themostpart
of Lactobacillus species bacteria (Lamont et al., 2011). Other potentially
virulent organisms, such as Gardnerella vaginalis, group B streptococci,
Staphylococcus aureus, Ureaplasma urealyticum (U. urealyticum) or Myco-
plasma hominis (M. hominis) occasionally displace lactobacilli as the pre-
dominant organisms in the vagina, a condition known as bacterial
vaginosis (BV) (Eschenbach, 1993; Casari et al., 2010). BV is present in
24–25% of women of reproductive age (Ralph et al., 1999; Wilson
et al., 2002) and causes a rise in the vaginal pH from the normal value
of 3.8–4.2 up to 7.0. It is usually asymptomatic but may result in a
vaginal discharge, which can be grey in colour with a characteristic
‘ﬁshy’ odour. BV is diagnosed using microscopic examination of vaginal
swab samples for ‘clue cells’ and/or Nugent criteria and is commonly
treated with antibiotics, such as metronidazole (Donders et al., 2014).
Change of sexual partner, a recent pregnancy, use of an intrauterine
contraceptive device and antibiotic treatment have been identiﬁed as
plausible causes of BV (Hay, 2004; Smart, 2004). BV has been associated
withprematuredelivery (Hayet al., 1994) andwithmiscarriage (Donders
et al., 2009; Rocchetti et al., 2011; Tavo, 2013).
In a retrospective study from Albania, U. urealyticum and M. hominis
were present in 54.3 and 30.4% of the patients (150 hospitalized
women, presenting with infertility, who had had a miscarriage or medic-
ally induced abortion, Tavo, 2013). The prevalence of both pathogens
was signiﬁcantly higher among women with a history of miscarriage
(U. urealyticum: P ¼ 0.04 and M. hominis: P ¼ 0.02) and women who
reported more than one miscarriage (P ¼ 0.02 for both pathogens).
This study however has some weaknesses, as it is not clear whether
the comparisons made were with non-infected women with a miscar-
riage history or non-infected women with no miscarriage history and
themethod bywhich prevalence of microbeswas tested is not speciﬁed.
Data on the prevalence of group B streptococci and pregnancy
outcome in 405 Brazilian women with gestational age between 35 and
37 weeks was published in 2011 (Rocchetti et al., 2011). Overall,
25.4% of women were positive for Streptococcus agalactiae and infection
was associated, among other factors, with a history of miscarriage (odds
ratio (OR) 1.875; 95% conﬁdence interval (CI) 1.038–3.387).
Association of BV and particularly M. hominis and U. urealyticum was
reported from a study from Turkey (Bayraktar et al., 2010). In total 50
pregnant women with BV symptoms were tested for M. hominis and
U. urealyticum and observed until end of pregnancy. The pregnancy out-
comes of 50 asymptomatic pregnant womenwere used as controls. Mis-
carriagewas reported in 12 symptomaticwomen, in 8ofwhichM.hominis
and/orU.urealyticum infectionwasconﬁrmed.However, thedeﬁnitionof
miscarriage used in this study was ‘less’ than 36 weeks. Furthermore,
comparative analysis between the two groups was not carried out.
Ureaplasma urealyticum was also detected in 25% of 101 gestational
tissue samples (chorion, amnion, umbilical cord) from miscarriage
cases that were otherwise normal. Second most common pathogens
wereM. hominis and group B streptococci at 11.1%, whereas all controls
were not infected (Allanson et al., 2010).
In a further study using a cohort of 759 Belgian pregnant women fol-
lowing microbiological evaluation of vaginal ﬂora, 8.4% of participants
in the cohort presented with BV and were not treated (Donders et al.,
2009). BV was positively correlated with miscarriage, as 2% of positive
women miscarried before 25 weeks gestation; with an OR of 6.6 (OR
6.6; 95% CI 2.1–20.9). An absence of lactobacilli was also associated
with miscarriage (less than 25 weeks; OR 4.9; 95% CI 1.4–16.9,
Donders et al., 2009).
These studies indicate an association of BV with miscarriage. As BV is
treatable, screening programmes for pregnant women can be used to
prevent adverse pregnancy outcome. Current guidelines from the USA
advise against screening asymptomatic pregnant women (U.S. Preventive
Services, 2008). The same principle is applied in Canada (Yudin and
Money, 2008) and the UK as of November 2014 (UKNational Screening
Committee, 2014). A recent Cochrane review, including 7847 women in
21 trials, founddecreased riskof latemiscarriagewhenantibiotic treatment
was administered (relative risk (RR) 0.20; 95% CI 0.05–0.76; two trials,
1270 women, ﬁxed-effect, I2 ¼ 0%). As the authors highlight, further
studies are required to establish the effect of screening programmes to
prevent adverse pregnancy outcomes (Brocklehurst et al., 2013).
Brucellosis
Bacteriaof the genusBrucellacan infect avarietyofwild anddomesticated
mammals. Cattle and deer are susceptible to Brucella abortus (B. abortus)
whereas Brucella melitensis affects goats and sheep, causing fever and
abortion; a disease known as brucellosis (Atluri et al., 2011; Moreno,
2014). Humans can contract infection via consumption of unpasteurised
dairy products (Corbel, 1997). Infection is detectedvia bacterial isolation
fromblood samples or serology (CDC—Centre forDisease andPreven-
tion, 2012a).
Kurdoglu and colleagues inTurkey (Kurdoglu et al., 2010), conducted a
case–control study examining the miscarriage rate of 342 pregnant
women with brucellosis compared with 33 936 uninfected women of
similar socioeconomic status treated in the same hospital. The research-
ers concluded that 24.14%of infectedpregnantwomenmiscarried versus
7.59% of the controls. This result however could be inﬂuenced by statis-
tical power, as the cases are 100 times smaller than the control group.
The seroprevalence of brucellosis among 445 miscarriage cases and
445 control pregnant Jordanian women with no history of miscarriage
consecutively recruited, matched for age, socioeconomic status and
area of residence, was not signiﬁcantly different (Abo-shehada and Abu-
Halaweh, 2011). In the paper the researchers state that a sample of 441
was adequate as theprevalenceof brucellosis is 8% in high-risk patients in
contactwith livestock (Abo-Shehada et al., 1996), though their reference
for statistical power could not be reviewed. The overall prevalence was
similar in both groups; 1% in controls and 1.8% in cases.
The evidence suggests brucellosis is still a risk factor for miscarriage in
areas where the infection is endemic in farm animals. This is in accord-
ance with older studies that have reported high miscarriage rates
among women with brucellosis (Lulu et al., 1988; Khan et al., 2001).
Chlamydia trachomatis
Chlamydia trachomatis, an obligate intracellular bacterium, is the most
common sexually transmitted bacterial disease worldwide (Howie
et al., 2011). The prevalence of the disease is high, estimated at 101
million new cases in 2005 worldwide (World Health Organisation,
2011). Though in women it is often asymptomatic, untreated
Infections and miscarriage 3
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C. trachomatis infection can result in mucopurulent cervicitis (Brunham
et al., 1984), acute urethral syndrome (Stamm et al., 1980) and pelvic in-
ﬂammatory disease (PID) (Paavonen and Lehtinen, 1996).Chlamydia tra-
chomatis infection is a known risk factor for ectopic pregnancy and
preterm birth (Martin et al., 1982; Hillis et al., 1997; Egger et al., 1998;
Kova´cs et al., 1998; Bakken et al., 2007; Shaw et al., 2011). Diagnosis is
carried out by PCR on vaginal swab samples and treatment includes
the administration of antibiotics, such as tetracyclines, azithromycin or
erythromycin (Brocklehurst and Rooney, 2000; MedlinePlus, 2014).
The most recent case–control study investigating a potential associ-
ation of C. trachomatis and miscarriage was published in 2011 (Baud
et al., 2011). Using an enzyme-linked immunosorbent assay (ELISA) to
detect C. trachomatis antibodies in sera, as well as a standard vaginal
swab forC. trachomatisdetection by PCR, on145 cases and261 controls,
a positive association with miscarriage was observed. Immunoglobulin
(Ig)G antibodies against C. trachomatis were present in higher levels in
the miscarriage group (15.2%) than in the controls (7.3%; P ¼ 0.018).
The same pattern was observed for IgA antibodies only after adjustment
for age, origin, education and number of sexual partners. Furthermore,
C. trachomatis was detected using PCR in the placentae from cases
more often than those from controls (4.0 and 0.7% respectively, P ¼
0.026). Subsequently, an observational study from Finland on 4920
womenwith genital tract infections has suggested that late complications
can occur in C. trachomatis infected pregnant women (Kortekangas-
Savolainen et al., 2012). However there was no control group in this
study and neither were the terms ‘early’ or ‘late’ pregnancy deﬁned,
therefore limiting extrapolation of the ﬁndings.
In a study from Serbia, 21.3% of 54 miscarriage cases were shown to
have persistent C. trachomatis infection as determined by levels of sera
IgA against C. trachomatis major outer membrane protein (Arsovic
et al., 2014). The authors suggest an association between persistent
C. trachomatis infection andmiscarriage, however these caseswere com-
pared only against patients with tubal infertility and not uninfected preg-
nant women.
Chlamydia trachomatishasbeenstudiedextensively anda lotof dataare
available for this infection from over three decades of research. Contra-
dicting studies have been published, resulting in conﬂicting evidence
regarding the role of C. trachomatis in miscarriage (Feist et al., 1999;
Wilkowska-Trojniel et al., 2009). Taking into account the most recent
ﬁndings and the increase in screening programmes worldwide, such as
the screening offered to all pregnant women in the USA (CDC, 2014),
public awareness of the possible risk of C. trachomatis infection to a
future pregnancy might be advisable.
Mycoplasma genitalium
Mycoplasma genitalium is a sexually transmitted bacterium, known to
cause urethritis, cervicitis and PID, but infection can also be asymptom-
atic (Taylor-Robinson and Jensen, 2011). It has been suggested that
M. genitalium can enhance human immunodeﬁciency virus (HIV) infec-
tion and transmission (NapieralaMavedzenge andWeiss, 2009); diagno-
sis is via PCR on urine samples (CDC, 2012b) and treatments include
azithromycin and doxycycline (Horner et al., 2014). The only published
study of this infection, is a case–control study from the USA on 392
women with miscarriage before 22 weeks of gestation and 802 healthy
pregnant controls, and used data from participants originally enrolled
in another study. Overall, M. genitalium had a prevalence of 5.9% but
no association with miscarriage was found (Short et al., 2010).
Q fever
Q fever is a zoonotic infection, caused by the bacterium Coxiella burnetii
(Maurin and Raoult, 1999). Infection is most commonly observed in
humans who come into close proximity to livestock. Coxiella burnetii is
usually transmitted via inhalation of infectious aerosols from animal
ﬂuids (Maurin and Raoult, 1999; van der Hoek et al., 2010). Infection is
asymptomatic in half of all cases in adults but can present as an unspeciﬁc
illness combined with pneumonia or hepatitis. Q fever is conﬁrmed via
PCRonblood samples (CDC,2013).Recommended treatment in symp-
tomatic adults and children is doxycycline administration. In pregnant
women, Q fever infection has been associated with adverse pregnancy
outcomes, as in a recent report from the United States Centres for
Disease Control and Prevention (CDC) (Anderson et al., 2013).
However, as the authors note, studies investigating serological evidence
of infection and miscarriage have produced contradictory results.
Screeningof pregnantwomen is not currently recommended in theEuro-
pean Union (Munster et al., 2012).
Two Danish studies, one in 2012 and the second in 2013, concluded
that C. burnetii is not linked to miscarriage (Nielsen et al., 2012, 2013).
Both used randomized sera samples from the Danish National Birth
Cohort. The ﬁrst study was powered to detect whether infection
could be associated with miscarriage. The presence of infection was
investigated in a case groupof 218womenwithmiscarriage (loss of preg-
nancy prior to 22 weeks of gestation) compared with 482 healthy preg-
nancies. The second study focused on pregnancy outcomes of 397
women exposed to cattle and sheep (high risk of exposure to
C. burnetii infection) versus 459 women that had no contact with
animals. Coxiella burnetii prevalence was 5% in cases and 6% in controls
of the ﬁrst study, whereas in the second study 19.5% of all women
were positive, however 87% of these women had contact with livestock.
Nielsen and colleagues (Nielsen et al., 2012) reported one positive mis-
carriage case (0.46%) and 3 (0.67%) seropositive among controls
whereas in the second study two miscarriages were positive (Nielsen
et al., 2013). These results suggest that, despite presence of C. burnetii in-
fection especially in pregnant women in proximity with cattle and sheep,
this bacterium does not seem to bewidely associatedwith adverse preg-
nancy outcome, although individual cases have been reported.
Syphilis
Syphilis is a bacterial infection that can be transmitted sexually or via
contact with the blood of an infected person. It is caused by Treponema
pallidum, diagnosed using PCR, and is treated with antibiotics (Cohen
et al., 2013). Stage one symptoms include a highly contagious sore that
develops during stage two to a rash accompanied by sore throat. The
third and ﬁnal stage is tertiary syphilis, which is not contagious but is
very harmful.
Casal and colleagues (Casal et al., 2012) assessed risk factors asso-
ciated with syphilis and pregnancy outcomes in a Brazilian population.
The cases consisted of women positive for syphilis, 169 with live
births and 68 who had an adverse pregnancy outcome. This included
miscarriage, stillbirth and neonatal death grouped together. The
control group of women negative for syphilis included 219 women
who had live births and 83 with adverse pregnancy outcome. Syphilis
was signiﬁcantly associated with history of miscarriage (OR 3.31; CI
2.20–4.99; P, 0.0001) after testing using a multiple regression
model. Most of the pregnancies resulting in live births were not
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completely asymptomatic when infection was present, resulting in out-
comes such as prematurity, low birthweight and respiratory problems,
among others. They also observed that maternal syphilis was asso-
ciatedwith illegal drugs, alcohol, no counselling on syphilis, sexual activ-
ity initiation at 16 years of age or younger, two ormore sexual partners
during the preceding 1.5 years, life in a householdwith a low incomeand
poorer sanitation; all factors thatmay also have a detrimental impact on
reproductive outcome.
A study from China reported that, following a screening programme
aiming to prevent mother-to-child syphilis transmission, the adverse
pregnancy outcomes including miscarriage were reduced from 27.3%
in 2003 to 8.2% in 2011 (Hong et al., 2014).
The effect of syphilis on pregnancy has been a subject of interest for
almost 100 years; general consensus is that syphilis can haveadevastating
effect on fetuses resulting in miscarriage, stillbirth and congenital trans-
mission (Temmerman et al., 1992; Oswal and Lyons, 2008). Syphilis
screening programmes are in effect in the USA and EU (CDC, 2014;
Janier et al., 2014).
Viral infections
Herpes virus infections
The Herpes family of DNA viruses includes a number of pathogenic
viruses of humans (Human Herpes Viruses/HHV) that can remain
latent in the host and can reactivate (Whitley and Roizman, 2001).
Twomembers of this family, HSV-1 (HHV1) and HSV-2 (HHV-2) estab-
lish latency in neuronal cells andon reactivation can causeherpes genitalis
or labialis (Margolis et al., 2007). Cytomegalovirus (CMV) (HHV-5) is
also a very common virus, acquired by most people during childhood
(Chisholm and Lopez, 2011). CMV infects mostly myeloid cells and is
never eradicated from the body (Koch et al., 2006). Herpes viruses
can be diagnosed using PCR in sera samples (Singh et al., 2005).
HSV-1 and HSV-2
HSV1 and/or HSV2 DNAwere detected in 43.5% of 95 frozen tropho-
blastic tissue samples from Greek women with spontaneous pregnancy
loss compared with 16.7% of women undergoing elective abortion (n ¼
35, P ¼ 0.03, Fisher’s exact test) (Kapranos and Kotronias, 2009). Using
in situ hybridizationHSVDNAwas detected in the trophoblast of 18 out
of 25HSVpositive cases. The authors concluded thatHSV seems to have
a role in early miscarriage, although they did not distinguish between the
two types of HSV.
These data are supported by a more recent study from Korea (Kim,
et al., 2012b). The authors of this study tested sera of 500 pregnant
women for HSV-2 and 85 (17%) were seropositive. Most of the
women in both groups also tested positive for rubella, varicella zoster
(HHV-3) and hepatitis B (HEPB), however the authors adjusted for
this. Of HSV-2 seropositive women, 38.8% had a history of miscarriage
compared with 29.6% of the control group (P, 0.05).
A possible association of HSV1 and HSV2 with miscarriage cannot be
ascertained from these reports and further studies are required.
Human CMV/HHV-5
Hadar and colleagues studied a group of seropositive 59 women with
peri-conceptional CMV infection, which occurred between 4 weeks
prior to the last reported menstrual period and up to 3 weeks after
the expected date of the period. Out of these women, four had
miscarriages before undergoing amniocentesis to conﬁrm intrauterine
infection. The remaining patients either elected to terminate the preg-
nancy or gave birth to live infants. No conclusion could be drawn with
regards to miscarriage association as no controls were included in this
study (Hadar et al., 2010).
Data from a Malaysian study (Saraswathy et al., 2011) showed that
anti-CMV IgG antibody was detected in 84% of healthy pregnant
women as well as women with adverse pregnancy outcome, including
17 cases of miscarriage.
Despite the lack of recent studies supporting an association of CMV
with miscarriage, in vitro studies have shown that CMV infection can
result in placental dysfunctions (see below). However, further studies
are required to elucidate the true role of CMV in adverse pregnancy out-
comes.
Human papillomavirus
Human papillomaviruses (HPV) comprise a group of over 150 different
types of small DNAviruses someofwhich cause common sexually trans-
mitted infections (Cutts et al., 2007). Sexually transmitted HPV infection
has a prevalence rate of 11.7% in the general female population of repro-
ductive age (Bruni et al., 2010). According to CDC, sexually transmitted
HPV prevalence nationwide in the USA among women 14–59 years old
was 42.5% in 2003–2006, an estimationbasedon positive servicovaginal
swab tests (Hariri et al., 2011). Persistent infectionwith high-risk types of
HPV (themost prevalent being HPV 16/18 worldwide) have been asso-
ciated with cervical cancer, and others (HPV 6/11) with genital warts
(Cutts et al., 2007; Crosbie et al., 2013). The vast majority of infections
are asymptomatic and clear naturally without causing long-term disease
and a vaccine is now available for types 6, 11, 16 and 18 (Cutts et al.,
2007). HPV infection cannot be diagnosed by blood tests, however
PCRon cervical cell samples is used to determine speciﬁc viral genotypes
following a positive Papanicolaou (PAP)-test (Molijn et al., 2005).
The results of recent studies into the effects of HPV infection upon
miscarriage are contradictory (Perino et al., 2011; Skoczyn´ski et al.,
2011; Yang et al., 2013). A study in China on the effect of HPV on the
pregnancyoutcomeof IVF treatedpatients foundnodifference inmiscar-
riage rates between women with abnormal cervical cytology who had a
positive high risk HPV test (n ¼ 56) and those who tested negative for
high-risk HPV (n ¼ 56, Yang et al., 2013). A second study from Poland
tested for 33HPVgenotypes and also for speciﬁcHPV16/18DNApres-
ence in placentae from miscarriages (n ¼ 51) and from term deliveries
from women who showed no signs of systemic infection (but were not
tested, n ¼ 78). They found HPV DNA in 17.7% of miscarriage cases
and in 24.4% control placentae. A total of 11.8% of miscarriages and
12.8% of normal placentae were positive for HPV 16/18, but none of
these differences reached statistical signiﬁcance (Skoczyn´ski et al.,
2011). Both of these studies suggest that HPV infection in women has
no effect on pregnancy outcome, although no more than 150 women
were examined in either study.
Conversely, results from a 2011 study signiﬁcantly associated male
partner HPV infection with miscarriage rate in 199 couples attending
IVF clinics in Italy (66.7% in HPV infected couples versus 15% of controls
with no HPV infection, P, 0.01, Perino et al., 2011). The researchers
also identiﬁed that all pregnancies in couples where both partners
were infected resulted in miscarriage (n ¼ 9).
These studies present contradictory data, however the ﬁrst two
examined infection in female partners whereas the second one
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investigatedmale partners. Interestingly, an older study (Hermonat et al.,
1997) reportedHPVDNApresence in 15/25 early miscarriage samples
compared with 3/15 ﬁrst trimester elective abortion samples. Further
well-designed, adequatelypowered studiesare required to fully elucidate
the role of HPV as a potential risk factor formiscarriage, whilst consider-
ing the role of an infected male partner as there are indications of a po-
tential role in early miscarriage (Garolla et al., 2011).
Parvovirus infection
Parvoviruses belong to the Parvoviridae family and are very small single
stranded DNA viruses that infect invertebrates and vertebrates
(Cotmore et al., 2014). Of interest to studies of miscarriage are
Adeno-associatedvirus(AAV),ParvovirusB19 (B19V)andBocavirus(BC).
AAV
Antibodies against several serotypes of AAV show infection in various
tissues, but it is asymptomatic (Gao et al., 2004). AAV needs the help
of a helper virus, adenovirus, to replicate. Despite this, 80% of the
human population is seropositive for AAV, as diagnosed by PCR (Gon-
c¸alves, 2005).
No association of AAV infection with serotypes 2, 3 and 5 with recur-
rentmiscarriage (deﬁned as twoormore)was found in coupleswith sub-
fertility (Schlehofer et al., 2012). A total of 146 semen samples as well as
134 endocervical samples from couples attending a fertility clinic were
tested for the presence of AAV DNA and 14.9% of female and 19.9%
of male samples were positive. No associations with other infectious
pathogens, semen quality or subsequent fertility issues were indicated.
In another study (Pereira, 2010), the presence of AAV was examined
in 81 patients, divided into three groups: 13medically induced abortions,
29 miscarriages and 39 ‘undetermined’ (including 66 decidua and 52
ovarian biopsies from the same patients). AAV DNA was detected in
23/81 (28.4%) of cases for at least one of the decidual or ovular frag-
ments. Furthermore, 22/68 (32.3%) of spontaneous and 7.7% (1/13)
of elective abortions (classiﬁed according to patient information)
tested positive. The authors grouped caseswith conﬁrmed type of abor-
tion and observed 28.6% (12/42) and 2.4% (1/42) AAV positive ‘for
spontaneous and medically induced abortion, respectively (P, 0.05)’.
The classiﬁcation of samples used as well as deﬁnition of the various
groups compared in this study are unclear from the paper description,
thus interpretation is challenging. The authors suggest a ‘casual associ-
ation’ of AAV to miscarriage.
Despite thedetectionofAAVDNAin somemiscarriage cases, there is
inconclusive evidence for a role for this virus in miscarriage.
Parvovirus B19 (B19V)
Parvovirus B19 (B19V) is a small virus capable of causing different dis-
eases in humans, such as ‘Fifth disease’ during childhood (Young and
Brown, 2004). It is estimated that 50% of young men and women
have antibodies against B19V, determined via serology tests (Broliden
et al., 2006). The remaining 50% of women are at risk of developing in-
fection during pregnancy, which can lead to non-immune hydrops
fetalis, a well-established cause of fetal death (Silingardi et al., 2009).
A recent study from Northern Ireland examined 3921 women of
reproductive age and 33.5% of them were at risk of infection as they
had no antibodies against B19V (Watt et al., 2013). Though fetal loss
was reported in infected women with conﬁrmed presence of the virus
in miscarried fetuses, no increased association with miscarriage was
observed. However, the authors reported ‘inadequate follow-up’ of
pregnancies potentially associated with B19V infection.
In an earlier study of 72 pregnant womenwith B19V, it was noted that
the risk of vertical transmission is higher if infection occurs by gestational
week 20. Six out of eight cases of fetal loss observed were ‘attributed to
B19V infection’ without further elucidation. No conclusions regarding
the association were reached by the researchers (Bonvicini et al., 2011).
A higher percentage of IgM antibodies indicating recent infection was
observed inwomenwith adversepregnancyoutcomes (22.72%, n ¼ 88)
compared with 4.5% observed in 88 control healthy pregnant women
(Brkic et al., 2011). Interestingly, anti B19V IgG antibodies were higher
in controls than cases (70.5 and 53.4% respectively, P ¼ 0.046). An im-
portant limitation of this study is that the adverse pregnancy outcome
included miscarriage, non-immune hydrops fetalis and intrauterine
fetal death, thus the association of miscarriage alone with B19V is not
clear.
In a study fromNigeria, B19Vprevalence amongpregnantwomenwas
estimatedat40.7%, as 111outof 273patients in the studyhaddetectable
levels of either IgGor IgMantibodies, however thesewerenot associated
with a history of miscarriage (Emiasegen et al., 2011).
From the above, it is evident that a case–control studyonwomenwith
miscarriage versus healthy pregnant controls, statistically powered to
elucidate the role of B19V in miscarriage is required, as there are indica-
tions of high prevalence in pregnancy and fetal infection.
Bocavirus (BC)
The human BC is a newly discovered member of the parvovirus family
detected in 93% of sera of children older than 3 years old (Karalar
et al., 2010). In a study on 535 fetal biopsies (120miscarriages, 169 intra-
uterine fetal deaths and246 induced abortions), even thoughonly 10%of
women were seronegative, none of the fetuses tested positive and the
authors concluded that BC could not have a possible role in miscarriage
(Riipinen et al., 2010).
HIV
HIV is a retrovirus, and is most commonly transmitted via unprotected
sexual intercourse or sharing of equipment for intravenous drug use.
There are two types of HIV, HIV-1 and HIV-2, with the ﬁrst being the
most common (Gnann et al., 1987). The virus infects several cell types
of the host immune system, such as CD4+ T lymphocytes (Miedema
et al., 1988; Embretson et al., 1993), macrophages (Orenstein et al.,
1997) and dendritic cells (Gringhuis et al., 2010). Worldwide, the
World Health Organization (WHO) estimates that 34 million people
are living with HIV, diagnosed by HIV viral load blood tests (PCR)
(World Health Organisation, 2013a). Anti-retroviral treatment delays
the onset of severe symptoms and protects the patient from opportun-
istic infections, which are the main cause of death among HIV-positive
patients (Dybul et al., 2002).
A 2013 study from Nigeria examined 2381 pregnancies in 1702
women positive for HIV compared with 2381 pregnant non-infected
women fromthe samehospitals. Followingpretermdelivery,miscarriage
was signiﬁcantly associated with HIV positivity (OR: 1.37; CI: 1.1–2.3).
This association was retained after adjustment for several confounding
variables such as age, parity, history of miscarriage and others. The
infected women in this study were all receiving anti-retroviral treatment,
however different regimes were used during the years in which the study
was conducted. Limitations of this study include the number of controls
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not being clearly stated and lack of testing for other sexually transmitted
diseases (Ezechi et al., 2013).
In a study in Zambia 1229 HIV-positive pregnant women were fol-
lowed up (Kim et al., 2012a, b). The ratio of miscarriages to live births
was 3.1/100 andCD4 counts less than 350 cells/mm2were signiﬁcantly
associatedwithmiscarriage. Thewomenwere recruited during both ﬁrst
and second trimesters and none of the women who miscarried had
received anti-retroviral treatment. The study did not compare the
cases with uninfected pregnant women.
In a study of 382 Ugandan/Zimbabwean HIV-infected pregnant
women undergoing multiple anti-retroviral therapies (Gibb et al.,
2012), miscarriage and medically induced abortions occurring prior to
22 weeks of gestation were assessed as one factor, not separate out-
comes. Of note, fetal death after 22 weeks was classiﬁed as stillbirth.
Therefore, no conclusions regarding miscarriage speciﬁcally can be
drawn from this study. A study from India on 69 HIV-infected and 345
non-infected women demonstrated higher miscarriage/stillbirth risk
amongst the infected group, however again there was no distinction
between medically induced abortions and miscarriages (Darak et al.,
2011). In a retrospective analysis from Germany, 42% of HIV-positive
women attending an outpatient clinic for preconception counselling
became pregnant and only one miscarried (Gingelmaier et al., 2011).
HIV statuswasassociatedwithmiscarriage in a studyof1,218pregnant
women fromUganda (De Beaudrap et al., 2013). However, they deﬁned
stillbirth as the delivery of a non-living fetus ≥28 weeks gestation; and
miscarriage as the delivery of a non-viable fetus either at,28weeks ges-
tation or weighing ,500 g. Furthermore, as stillbirth and miscarriage
were grouped together as one outcome, no deﬁnite conclusions regard-
ing miscarriage can be drawn from this study.
To summarize, evidence suggests that HIV infection negatively affects
pregnancy; however, anti-retroviral treatment can reduce the risk of
adverse outcomes (Zolopa et al., 2009; Friedman et al., 2011). Further-
more, HIV has been associated with BV which could have a detrimental
roleonpregnancyoutcome (Ledruet al., 1997).Thepresenceofmultiple
diseases could further compromise a pregnancy. As most of the studies
suggest, consultation and monitoring of HIV-positive women who wish
to become pregnant is desirable. Women during their ﬁrst antenatal
visit are offered HIV tests in the UK, USA and EU (European Centre
forDisease Prevention andControl, 2010; UKNational Screening Com-
mittee, 2013; CDC, 2014).
Polyomavirus BK
Polyomavirus BK infects up to 90% of the general population via an
unknown transmission route and is usually asymptomaticwith theexcep-
tion of immunocompromised individuals (Hirsch and Steiger, 2003).
Antibodies against the virus can be detected using sera samples and
PCR, urine cytology and viral immunostaining (Masutani, 2014).
Recent studies have investigated a potential role of BK virus infection
on adverse pregnancy outcomes. A study on patients with unexplained
villitis (infection of the placental villi associated with adverse pregnancy
outcomes) detected no BK in placenta from miscarriages (Cajaiba
et al., 2011). The authors state that ‘For cases with diffuse villitis, the ges-
tational age ranged from 31 to 41 weeks (average 37.2 weeks)’. It seems
therefore more suitable to address these cases as stillbirths, not
miscarriages. In another study from Italy, samples from ﬁve miscarried
fetuses with chorioamnionitis andmiscarriages due to chromosomal ab-
normalities (controls), BK was detected in fetal organs (Boldorini et al.,
2010). Though this provides possible proof of vertical transmission of
the virus, as it was detected in four out of ﬁve chromosomally abnormal
controls and three out of ﬁve cases, the authors concluded that BK infec-
tiondoesnothavea role inmiscarriage. In accordancewith theﬁrst study,
the fetuses were between the 15th and the 28th week of gestation, so
some of them were stillbirths according to our review’s classiﬁcation.
Moreover, the fetuses were not matched for gestational age. In both
studies, the numbers were small and no early miscarriages were
tested. The question whether BK virus could be associated with
miscarriage requires therefore further investigation.
Dengue fever
Dengue fever is a disease caused by four viruses of the single stranded
RNA ﬂaviviridae genus (DEN1-4), transmitted via mosquito bites
usually in tropical and sub-tropical climates worldwide.WHOestimates
40–50 million new cases every year. Dengue is a ﬂu-like illness with no
vaccination and treatment currently available. Diagnosis is difﬁcult as
symptoms resemble other diseases, however usual approaches include
DNAand antibody detection in serum samples using PCR and ELISA, re-
spectively (CDC, 2012).
The role of dengue fever inmiscarriagewas examined in a prospective
study from Malaysia on 115 women with miscarriage up to 22 weeks of
gestation and 296 healthy pregnant controls. This study found signiﬁcant
association of recent dengue fever infectionwithmiscarriage after adjust-
ing for confounders such asmaternal age, gestational age, parity and eth-
nicity (5.3% in cases versus 1.7% in controls, adjusted OR 4.2, 95% CI
1.2–14, P ¼ 0.023, Tan et al., 2012).
In a case series report from Sri Lanka, two out of ﬁfteen pregnant
women experienced fetal death at 24 and 35 weeks of gestation,
however the study provides no evidence of vertical transmission to the
fetuses (Kariyawasam and Senanayake, 2010). In another case series
report from French Guiana the authors reported two late miscarriages
in 53 pregnant women with dengue fever. However, the infection
could not be connected to the adverse pregnancy outcome (Basurko
et al., 2009).
A systematic reviewon 30 studies concluded that it is unclearwhether
dengue fever is associated with adverse pregnancy outcomes (Pouliot
et al., 2010). Based on recent evidence however, we can conclude
that dengue fever seems to be a risk factor for miscarriage; therefore it
is advisable to raise awareness regarding protectivemeasures in high-risk
areas and for people travelling to those areas.
HEPB and HEPC
The HEPB virus is a member of the Hepadnavirus family of small DNA
viruses and the HEPC virus is a member of the ﬂaviviridae genus of
single stranded RNA viruses. Both viruses cause liver inﬂammation and
disease and are both found in body ﬂuids. HEPB is often resolved
within a couple of months, however HEPC can develop into a chronic
disease. Both diseases are diagnosed using blood serological tests
(Gretch, 1997; Krajden et al., 2005).
In a case–control study fromChina, 75 couples that received assisted
reproduction treatmentwere followed up, divided into a groupwith one
partner diagnosed with chronic HEPB infection and a control groupwith
both parents seronegative for HEPB (Ye et al., 2014). The early miscar-
riage rate (gestational week range not speciﬁed) was 44% in the case
group compared with 9.1% in the control group (P ¼ 0.043, Fisher’s
exact test). Highest miscarriage rates (60%) were observed when
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mothers were seropositive and fathers seronegative (P ¼ 0.03). Using
PCR, HEPB DNA was detected in 6/62 ‘abandoned embryos’ from
the case group, whereas all embryos of the control groupwere negative.
These results suggest a possible role of chronic HEPB infection in
miscarriage.
Conversely, a cross-sectional study from Yemen examined the asso-
ciation of miscarriage with HEPB and HEPC infection in pregnant
women, and found that 10.8% of women were positive for HEPB (95%
CI: 8.0–14.0%) and 8.5% for HEPC (95% CI: 6.0–11.5%). No associ-
ation of infection with miscarriage was apparent after multivariate ana-
lysis (Murad et al., 2013).
These studies raise questions regarding the role of persistentHEPB in-
fection during pregnancy. At the moment, screening programmes of
pregnant women for HEPB and HEPC during their ﬁrst antenatal visit
in the USA and UK aim to prevent adverse pregnancy outcome (UKNa-
tional Screening Committee, 2013; CDC, 2014).
Rubella
Rubella is a mild childhood disease that, if acquired during the ﬁrst 16
weeks of gestation, can result in miscarriage and serious fetal defects
(Banatvala and Brown, 2004). A vaccine has been available for several
years resulting in signiﬁcant reduction in new cases according to the
latest WHO progress report (Reef et al., 2011). Regardless of this pro-
gress, it is important to be aware that there remain a number of unvac-
cinated pregnant women in Europe and worldwide that do not have
access to vaccination and who are still at risk of adverse pregnancy
outcome due to rubella (Metcalf et al., 2011; Muscat et al., 2014).
Inﬂuenza virus
A study of the 1918 Inﬂuenza pandemic concluded that it resulted in a
decrease of live births due not only to high mortality but also to an in-
crease of early miscarriages in pregnant women who were infected by
the virus (Bloom-Feshbach et al., 2011). In a case series report regarding
the H1N1 Inﬂuenza A pandemic, six women were admitted to intensive
careandhadadversepregnancyoutcomes, howeveronlyone seriously ill
patient had a spontaneous abortion as four cases occurred during the
third trimester (Oluyomi-Obi et al., 2010).
Protozoan infections
Malaria
Malaria is caused by infection with protozoa of the genus Plasmodium
(P. falciparum, P. vivax, P. malariae, P. ovale), is transmitted via mosquito
bites and is endemic in more than 100 countries in Africa, Asia and
South America (World Health Organisation, 2013b). In 2012 there
were an estimated 207 million cases of malaria resulting in an approxi-
mately 627 000 deaths (90% of all malaria deaths occur in sub-Saharan
Africa) (World Health Organisation, 2013b). Symptoms include fever,
sweats, headache and diarrhoea and can be treated using different
drugs depending on the symptoms and the speciﬁc pathogen causing
the disease such as atovaquone plus proguanil or doxycycline (Kar and
Kar, 2010). Malaria parasites are identiﬁed by microscopit examination
of patients’ blood samples. In 2007, 54.7 million pregnancies occurred
in areas with endemic P. falciparum malaria and a further 70.5 million in
areas with exceptionally low malaria transmission or with P. vivax only
(Dellicour et al., 2010). Plasmodium can bind chondroitin sulphate A
expressed on trophoblast and this is what causes local parasitaemia in
the placenta (Agbor-Enoh et al., 2003). Maternal disease is most
severe in primigravidawomen, and it reduceswith each pregnancy as im-
munity builds up to those parasites that target the placenta (Fried et al.,
1998).
Women with asymptomatic and symptomatic malaria (single episode
before 14weeks of gestation) are at a higher risk ofmiscarriage (adjusted
OR 2.70, 95%CI 2.04–3.59 and 3.99, 95%CI 3.10–5.13, respectively).
This study included 3527 women with miscarriage and 14 087 women
that gave birth to livebabies inThailand. The risk ratioswerenot different
for both P. falciparum and P. vivax (McGready et al., 2012).
De Beaudrap et al. (2013) also studied malaria during pregnancy in
Uganda. In 1218 pregnant women no association of malaria with
adverse pregnancy outcome was shown but an association with HIV
status was demonstrated, as described above.
An association of malaria with adverse pregnancy outcomes, and
more speciﬁcally miscarriage, is evident from the above studies. Preven-
tion measures and screening of pregnant women at risk of malaria infec-
tion are advised.
Toxoplasmosis
Prevalence of Toxoplasmosis differs across the world, from 20–40% in
the UK and USA (Food Standards Agency, 2012) to 70% in tropical
countries (Klaren and Kijlstra, 2002). In a recent study from London,
17.32% of 2610 samples tested were seropositive (Flatt and Shetty,
2013). Even thoughmostpatients areasymptomatic, immunocomprom-
ised individuals are susceptible to developing severe disease andwomen
who become infected whilst pregnant can pass the infection vertically
(Jones et al., 2001). The presence of T. gondii is conﬁrmed by antibody
detection.
Alvarado-Esquivel et al. (2014) showed that 6.7%of326womenwith a
history of miscarriage had been exposed to T. gondii. This study however
didnot includeacontrol groupwithnohistoryofmiscarriage.Miscarriage
or stillbirth occurred in 28 out of 190 pregnant cases with toxoplasmosis
presenting in England and Wales between 2008 and 2012, however
these are data from the surveillance programme currently in place and
not part of a study (Halsby et al., 2014). In a study on serum samples
from 100 women who had miscarried, 86% of which were during the
ﬁrst trimester of pregnancy, 55% were seropositive for IgG against
T. gondii (Vado-Solis et al., 2012), however, no comparison to uninfected
pregnant women was made. A meta-analysis of several Mexican studies
also indicates that infection rates are higher in women with miscarriage
(Galvan-Ramirez et al., 2012). Despite this, as the authors highlight, only
three out of the 132 studies included in their systematic review, were
focused on women who had a miscarriage.
The likelihood of association of T. gondii infection resulting in miscar-
riage is highlighted by the present review of recent studies. Taking into
account the signiﬁcant worldwide prevalence of this protozoan infec-
tion, screening of pregnant women is recommended if it is established
that this infection presents a signiﬁcant risk for adverse pregnancy
outcome.
How do infections lead to miscarriage?
Pregnancy is a complex process involving multiple cell types and regu-
lated by several sophisticated mechanisms, which are still not fully
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clariﬁed despite years of research. To examine the negative impact of
infections to pregnancy, we ﬁrst need to understand how a normal, suc-
cessful pregnancy is established.
Maternal-fetal interface: morphology, implantation process and
the role of the immune system
The human endometrium is composed of several different cell types, in-
cluding luminal and glandular epithelial cells, stroma with stromal ﬁbro-
blastic cells, immune cells and blood vessels. During every menstrual
cycle, in response to ovarian estrogen and progesterone via a process
called ‘decidualisation’, the endometrial stromal compartment under-
goes morphological and structural transformation to become receptive
to implantation. Prior to implantation, the trophoblast differentiates into
the growing blastocyst as it travels from the Fallopian tube to the uterus.
The ‘implantation window’, during which the uterus is receptive to the
embryo, is usually between 6 and 12 days after ovulation (Rashid et al.,
2011). The blastocyst attaches to the receptive endometrium utilizing
adhesion proteins, called integrins, during the implantation window
(Fig. 2A, Merviel et al., 2001). Placenta formation begins as the tropho-
blast comes into contact with the epithelium and differentiates further
into syncytiotrophoblast that invades the epithelial layer. Various other
molecules, both from the maternal and fetal side, are involved in this
process (reviewed in Dimitriadis et al., 2005; Tranguch et al., 2005;
Achache and Revel, 2006; Chen et al., 2009). Syncytiotrophoblasts, sup-
ported by the decidualised stroma (Godbole et al., 2011), penetrate the
endometrium and surround the embryo,whilst it embeds itself in the de-
cidual stroma. A second trophoblast layer, the cytotrophoblast, is an
inner layer without contact with the maternal cells. During the tropho-
blast invasion, cavities called lacunae develop, which, as they get ﬁlled
with maternal blood, bring the maternal circulation into contact with
the placental villi, thus marking the onset of placental circulation that
includes exchange of nutrients and waste between the embryo and
mother. At days 10–12 of gestation, the embryo is completely embed-
ded in the endometrium, the epithelium has grown over it and the im-
plantation process is complete (Fig. 2B). The three placental zones
are now distinguishable: the early chorionic plate near the embryo,
the intervillous space with the villous trees and the primitive basal
plate in contact with the maternal endometrium (Pijnenborg et al.,
1980, 1981). Simultaneously, endovascular trophoblast cells stemming
from the basal plate invade the walls of the spiral arteries, replacing the
maternal muscular and endothelial cells with trophoblast cells, trans-
forming the arteries into large diameter and low resistance blood
vessels (Lyall, 2005).
The role of the immune system in a successful pregnancy is crucial
(Fig. 3A). Whilst the immune tolerance of the semi-allogeneic fetus is
maintained, several components of the immune system fulﬁl their desig-
nated roles in preparation for implantation as well as during gestation
(Entrican, 2002; Chaouat et al., 2004). Natural killer (NK) cells, macro-
phages and dendritic cells have all been detected in the feto–maternal
interface (Guleria and Pollard, 2000; Moffett-King, 2002; Gardner and
Moffett, 2003). Cytokines such as interleukin (IL-10), colony stimulating
factor (CSF-1) and transforming growth factor-b among others have
been linked with the implantation process and are expressed in
uterine cells (Altman et al., 1990; Guleria and Pollard, 2000; Thaxton
and Sharma, 2010). Implantation induces an inﬂammatory response
because of invasion and damage of maternal tissue, with many cells
undergoing apoptosis (Jerzak and Bischof, 2002; Joswig et al., 2003).
Conversely, inﬂammatory cytokines such as interferon-g and tumour
necrosis factor alpha (TNF-a) are not usually expressed in the placenta
and have been associated with abortion in mouse models (Entrican,
2002).
Abnormal implantation, placentation or blood vessel transformation
are thought to result in miscarriage (Michel et al., 1990; Ball et al.,
2006). An active infection could interferewith the pregnancy by affecting
any of the above-mentioned processes as well as disrupt the immune
balance, whether it resulted in placental and fetal infection or not.
Examples of where we understand the mechanism of
infection-induced miscarriage
Formostof the pathogenswhere an association has been demonstrated,
theexactmechanism that leads from infection tomiscarriage is unknown.
Bacteria, protozoa and viruses utilize different mechanisms to infect their
host and each one seems to induce a unique cascade of events in the
feto–maternal interface, most of which remains to be determined. Our
knowledge is derivedmostly from animal studies and data on humanpreg-
nancies are scarce.
Multiplemechanisms can be utilized by pathogens to cross the placen-
tal barrier. Plasmodium, asmentioned previously, enters the host via the
maternal circulation and can infect and multiply in the trophoblast
(Fig. 3B), even though its natural target cells are red blood cells (Agbor-
Enoh et al., 2003; Moreno-Pe´rez et al., 2013). However, this mechanism
of crossing the placental barrier is speciﬁc to malaria. Listeria monocyto-
genes uses two bacterial surface proteins called internalin A and B to
invade the placenta, after passing from the intestinal barrier to themater-
nal circulation (Fig. 3B, Va´zquez-Boland et al., 2001; Lecuit et al., 2004;
Disson et al., 2008). The presence of pathogenic organisms in the pla-
centa induces a maternal immune response to infection that could
result in miscarriage.
The susceptibility of placenta and fetus to several viruses has been
investigated, as trophoblast cells have been identiﬁed as targets and
viruses such as AAV and CMV have been detected in fetal tissue. CMV
has been shown in vitro to replicate in trophoblast cells (Fig. 3B), in add-
ition to epithelial, stromal cells and macrophages that are known target
cells of the virus (Minton et al., 1994; Fisher et al., 2000; Sinzger et al.,
2008). In trophoblasts, CMV can induce an inﬂammatory response
that increases apoptosis (Chou et al., 2006). CMV has also been
shown to activate TNF-a, again leading to cell death (Chan et al.,
2002). TNF-a is normally expressed in low levels by the placenta (Entri-
can, 2002); in the mouse CBA × DBA/2 model TNF-a was shown to
increase fetal resorption via activation of NK cells, macrophages, and
Th1-type cytokines (Clark et al., 1998). Furthermore, decreased
levels of implantation-associated matrix metalloproteinases 2 and 9
(MMP2 and MMP9) in the early pregnancy villi of women with CMV in-
dicate compromised invasive capability, that could result in miscarriage
(Tao et al., 2011). These results suggest that CMV infection could lead
to placental dysfunction as well as suggest possible routes of fetal infec-
tion resulting in miscarriage.
Bacterial infections initiate different responses from the immune
system compared with viruses but gram-negative and gram-positive
bacteria are both capable of activating the innate immune system
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(Takeuchi et al., 1999; Yoshimura et al., 1999). Most of our
knowledge regarding bacterial infections and pregnancy comes from
studies in mouse models. Nitric oxide and prostaglandins produced in
the presence of bacterial lipopolysaccharides (LPS) were shown to be
associated with embryonic resorption, as inhibition of this pathway
reversed the effect in mice (Aisemberg et al., 2010). Poor uterine recep-
tivity and implantation failure due to exposure to bacterial LPS was also
reported in another study in mice (Deb et al., 2005).
Figure 2 Implantation of blastocyst in the maternal endometrium. (A) During the implantation window (Day 6–12 post conception), the blastocyst
adheres to the endometrium, and the placenta formation commences as the syncytiotrophoblast develops and invades the endometrium. (B) On Days
10–12 the implantation is completed as the embryo is encapsulated within the maternal tissue and the endometrial spiral arteries have been transformed
into low resistance blood vessels, thus marking the onset of the placental blood ﬂow.
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Bacteria, viruses and protozoa utilize variousmechanisms to infect fetal
and maternal tissues (Fig. 3B), a few of which have been elucidated yet
several remain unknown. These pathways are possibly implicated in
miscarriage caused by infection. Further research is however required,
as understanding the exact mechanisms behind infection-induced
miscarriages could lead to effective treatment and thus prevention.
.............................................................................................................................................................................................
Table I Summary of pathogens and their association with miscarriage.
Bacteria Viruses Protozoa
Associated with miscarriage † Bacterial vaginosis (includingMycoplasma hominis and
Ureaplasma urealyticum)
† Brucellosis
† Syphilis
† Cytomegalovirus
† Dengue fever (Flavivirus)
† HIV
† Rubella
† Malaria
(Plasmodium)
Little or no evidence for association
with miscarriage
† Coxiella burnetii
† Mycoplasma genitalium
† Adeno-associated virus
† Bocavirus
† Hepatitis C
† None
Conﬂicting evidence for association
with miscarriage
† Chlamydia trachomatis † Human papillomavirus
† Herpes simplex virus 1
and 2
† Parvovirus B19
† Polyomavirus BK
† Hepatitis B
† Toxoplasma gondii
HIV, human immunodeﬁciency virus.
Figure 3 Healthy and infected feto–maternal interface. (A) During a healthy pregnancy, the interaction between maternal decidua, vasculature and
immune cells (macrophages, uterine natural killer cells and dendritic cells) with fetal trophoblast and syncytial cells is the cornerstone of establishment
and progression of pregnancy. Molecules such as interleukin (IL-10), colony stimulating factor (CSF-1) and transforming growth factor-b are essential
for trophoblast invasion during the implantation process and are expressed by uterine cells. (B) Infections can disrupt the balance of feto–maternal inter-
actions. Plasmodium falciparum can infect trophoblast cells entering via thematernal bloodstream.Cytomegalovirus and Listeriamonocytogenes areexamples
of viral and bacterial infections known to interfere with trophoblast cells.
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Table II Summary of the sites of detection of pathogens in the studies in the review.
Microbe Site of detection
Fetus/placenta Vagina/cervix Serology/maternal blood/maternal urine Paternal sample
Adeno- associated virus Pereira (2010) Schlehofer et al. (2012)
Pereira (2010)
Schlehofer et al. (2012)
Bacterial vaginosis (including
M. hominis and U. urealyticum)
Allanson et al. (2010) Rocchetti et al. (2011)
Bayraktar et al. (2010)
Donders et al. (2009)
Bocavirus Riipinen et al. (2010) Riipinen et al. (2010)
Brucellosis Kurdoglu et al. (2010)
Abo-shehada and Abu-Halaweh (2011)
Chlamydia trachomatis Baud et al. (2011) Baud et al. (2011)
Kortekangas-Savolainen et al. (2012)
Arsovic et al. (2014)
Coxiella burnetii Nielsen et al. (2012, 2013)
Cytomegalovirus Hadar et al. (2010)
Saraswathy et al. (2011)
Dengue fever (Flavivirus) Basurko et al. (2009) Tan et al. (2012)
Kariyawasam and Senanayake (2010)
Basurko et al. (2009)
Herpes simplex virus 1 and 2 Kapranos and Kotronias (2009) Kim, et al. (2012a, b)
Hepatitis B Ye et al. (2014) Ye et al. (2014)
Murad et al. (2013)
Ye et al. (2014)
Hepatitis C Murad et al. (2013)
HIV Ezechi et al. (2013)
Kim et al. (2012a, b)
Gibb et al. (2012)
Darak et al. (2011)
De Beaudrap et al. (2013)
Human papillomavirus Skoczyn´ski et al. (2011) Yang et al. (2013) Perino et al. (2011)
Malaria (Plasmodium) De Beaudrap et al. (2013) McGready et al. (2012)
De Beaudrap et al. (2013)
Mycoplasma genitalium Short et al. (2010)
Parvovirus B19 Brkic et al. (2011)
Emiasegen et al. (2011)
Polyomavirus BK Cajaiba et al. (2011)
Boldorini et al. (2010)
Syphilis Casal et al. (2012)
Hong et al. (2014)
Toxoplasma gondii Alvarado-Esquivel et al. (2014)
Halsby et al. (2014)
Vado-Solis et al. (2012)
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Conclusions
A plethora of bacterial, viral and protozoan infectious agents have been
investigated to determinewhether they are associatedwith an increased
risk of miscarriage. The evidence presented in this review shows
that infections such as BV, malaria, CMV, dengue fever, brucellosis and
HIV may adversely affect pregnancy outcome. In contrast, there is no
current evidence to suggest that C. burnetii, adeno-associated virus,
Bocavirus, Hepatitis C andM. genitalium are associatedwithmiscarriage.
More importantly though, the lack of consensus regarding the effects
ofC. trachomatis, T. gondii,HPV,HSV1,HSV2, PolyomavirusBK,Hepatitis
B and B19V infection reveals a gap in knowledge that future research
should address, as these pathogens could potentially be harmful to
early pregnancy development (Table I). This issue is of particular import-
ance for public health practitioners as it could alter current policies of
prevention of infection, diagnosis and treatment in pregnant women.
Even in diseases such as malaria and rubella, where a causative role is
established, the underlyingmolecular cause ofmiscarriage is still unknown.
The mechanism that has been proposed to explain how CMV infection
could undermine a pregnancy could apply to other intracellular patho-
gens. Chlamydia trachomatis and U. urealyticum have been detected in
placental cells, therefore they could cause a similar response (Joste
et al., 1994; Baud, et al., 2011). It is well established that pregnancy is a
balance between tolerance and rejection, as the maternal immune
system is re-programmed to tolerate the allogeneic (paternal) fetal
antigens (Thellin andHeinen, 2003). An active infection could destabilize
this balance resulting in rejection, especially if it leads to a serious illness
of the mother. Evidently, further research is required to understand
the causes of pregnancy failure.
In severematernal infection, such as with inﬂuenza, HIV, dengue fever
and malaria, the maternal response may result in miscarriage instead of
a direct placental infection effect. However, pathogens such as Plasmo-
dium parasites and Dengue fever’s Flavivirus are known to be detected
in fetal tissue and placenta, as are a plethora of other pathogens
(Table II). This is of particular importance, as proof of vertical transmis-
sion thatcould interferewith anongoingpregnancy ismore likely to result
inmiscarriage than amaternal infection. Examination of fetal tissues from
infected mothers is essential to clarify whether vertical transmission is
possible for pathogens as this has not yet been elucidated and it is
evident from recent studies that an association is likely: for example, bru-
cellosis, Mycoplasma genitalium and Coxiella burnetii infections. A very
signiﬁcant issue is fetal specimen contamination in cases with presence
in the vagina of common viruses, such as HPV and HSV, as this does
not equate to causation of miscarriage.
One interesting outcome of our review was that studies regarding
infections and pregnancy outcome were conducted worldwide. Despite
this, it seemsthatmostof the studieswere fromcountries in thedeveloping
world where the prevalence of speciﬁc diseases is higher.
A commonly observed limitation of the studies presented in this
review was that few studies tested for the presence of other pathogens
except for the one of interest. Several pathogens are often associated
with one another, such as HIV with BV and malaria (Ledru et al., 1997;
Taha et al., 1998; De Beaudrap et al., 2013).
Furthermore, the deﬁnition of terms, such asmiscarriage and stillbirth,
may differ from the ones generally accepted in some studies, as men-
tioned previously. For example, loss of pregnancy up to 36 weeks was
considered miscarriage (Bayraktar et al., 2010), or in other cases less
than 22 gestational weeks (Nielsen et al., 2012). Universal terminology
guidelines are required to establish effective scientiﬁc communication.
The impact of immunization, if a vaccine is available such as in the case
of HPV, could be detrimental in cases of infection-induced miscarriage.
However, vaccine development for some of the pathogens of interest
in this review is a complicated process and has been unsuccessful so
far (Hafner et al., 2008; Mouquet and Nussenzweig, 2013).
To our knowledge, there are no EU guidelines regarding screening
for infectious diseases in pregnancy. Current screening guidelines in
the UK include offering tests for HepB, HIV, rubella (testing for sus-
ceptibility) and syphilis to pregnant women (Public Health England,
2015). Systematic screening for infections such as BV or CMV is not
currently recommended in theUK.Without accounting for cost, screen-
ing for pathogens highlighted as high risk for miscarriage in this review
should be reconsidered as an option worldwide.
Newpolicies includingpubliceducation toraiseawarenessandscreen-
ing programmes for appropriate pathogens associated with adverse
pregnancy outcomes could result in a decrease in the number of miscar-
riages.
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